|
Cerebral venous thrombosis: An experience with anticoagulation with low molecular weight heparin
Lalitha V Pillai, Dhananjay P Ambike, Satish Nirhale, S M K Husainy, Satish Pataskar
Critical Care Department, Lokmanya Hospital, Chinchwad, Pune, India
Correspondence Address:
Lalitha V Pillai
Director Critical Care Department, Lokmanya Hospitals, Chinchwad, Pune, Maharashtra - 411033
India
Cerebral venous sinus thrombosis [CVST] is often an infrequent cause of neurological dysfunction resulting in admissions in Intensive care units [ICU]. Because of its myriad presentation it may be under diagnosed. Unfractionated Heparin [UFH] has been advocated in treatment but needs frequent monitoring. We studied the clinical profile of patients of cerebral venous sinus thrombosis, use of low molecular weight heparin [LMWH] with emphasis on safety in 64 patients of CVST.
How to cite this article:
Pillai LV, Ambike DP, Nirhale S, Husainy S M, Pataskar S. Cerebral venous thrombosis: An experience with anticoagulation with low molecular weight heparin.Indian J Crit Care Med 2005;9:14-18
|
How to cite this URL:
Pillai LV, Ambike DP, Nirhale S, Husainy S M, Pataskar S. Cerebral venous thrombosis: An experience with anticoagulation with low molecular weight heparin. Indian J Crit Care Med [serial online] 2005 [cited 2013 May 22 ];9:14-18
Available from: http://www.ijccm.org/article.asp?issn=0972-5229;year=2005;volume=9;issue=1;spage=14;epage=18;aulast=Pillai;type=0 |
|
